Increased serum concentrations of tissue plasminogen activator correlate with an adverse clinical outcome in patients with bacterial meningitis

Winkler, F.; Kastenbauer, S.; Koedel, U.; Pfister, H. W.
October 2002
Journal of Neurology, Neurosurgery & Psychiatry;Oct2002, p456
Academic Journal
No abstract available.


Related Articles

  • Urokinase-Type Plasminogen Activator Receptor Regulates Leukocyte Recruitment during Experimental Pneumococcal Meningitis. Paul, Robert; Winkler, Frank; Bayerlein, Irene; Popp, Bernadette; Pfister, Hans-Walter; Koedel, Uwe // Journal of Infectious Diseases;3/1/2005, Vol. 191 Issue 5, p776 

    Tissue-type plasminogen activator (tPA) and urokinas c-type plasminogen activator (uPA) have been suggested to play an important role in inflammatory diseases. Increased levels of tPA, uPA, uPA receptor (uPAR), and their inhibitor, plasminogen activator inhibitor (PAT)-!, have been found in the...

  • Tissue plasminogen activator inhibitor in patients with systematic lupus erythematosus and thrombosis. Violi, Francesco; Ferro, Domenico; Valesini, Guido; Quinrarelli, Claudio; Saliola, Mirella; Grandili, Maria A.; Balsano, Francesco // BMJ: British Medical Journal (International Edition);4/28/90, Vol. 300 Issue 6732, p1099 

    Examines the relations among tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Correlation between tissue plasminogen activator and plasminogen activator inhibitor; Detection of lupus anticoagulants; Concentration of proteins.

  • The tissue-type plasminogen activator–plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Sashindranath, Maithili; Sales, Eunice; Daglas, Maria; Freeman, Roxann; Samson, Andre L.; Cops, Elisa J.; Beckham, Simone; Galle, Adam; McLean, Catriona; Morganti-Kossmann, Cristina; Rosenfeld, Jeffrey V.; Madani, Rime; Vassalli, Jean-Dominique; Su, Enming J.; Lawrence, Daniel A.; Medcalf, Robert L. // Brain: A Journal of Neurology;Nov2012, Vol. 135 Issue 11, p3251 

    The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in numerous brain pathologies including neurotrauma and ischaemic stroke. Tissue plasminogen activator is a serine protease that converts...

  • Oxidative Brain Damage by Peroxynitrite in Bacterial Meningitis: A Target for Adjunctive Therapy ? Kastenbauer, S.; Koedel, U.; Pfister, H-W. // Current Medicinal Chemistry - Central Nervous System Agents;Jun2002, Vol. 2 Issue 2, p109 

    The host response contributes greatly to the development of intracranial complications of acute bacterial meningitis. During recent decades, various host factors have been identified as potential targets for the adjunctive therapy of meningitis. Among these, radicals and oxidants are of great...

  • Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding. Perry, T.R.; Schentag, J.J. // Clinical Pharmacokinetics;2001, Vol. 40 Issue 9, p685 

    Ceftriaxone is a third-generation cephalosporin that is used for a variety of infections such as meningitis, gonorrhoea and community-acquired pneumonia. The most important aspects of its pharmacokinetics include a long half-life, excellent tissue penetration and saturable (dose-dependent) serum...

  • Alteplase.  // Reactions Weekly;7/17/2010, Issue 1310, p9 

    The article discusses the clinical cases of three patients with bacterial endocarditis who developed intracranial haemorrhages (ICH) after receiving intravenous infusions of tissue plasminogen activator alteplase for stroke.

  • Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Nilsson, Inga Marie; Ljungner, Harald; Tengborn, Lilian // British Medical Journal (Clinical Research Edition);5/18/1985, Vol. 290 Issue 6480, p1453 

    Examines the fibrinolytic components after venous occlusion and concentration of tissue plasminogen in patients with deep vein thrombosis or pulmonary embolism. Role of fibrinolytic inhibitors on venous thrombosis; Determination of plasminogen activators; Measurement of tissue plasminogen...

  • Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis. Brouwer, Matthijs; Meijers, Joost; Baas, Frank; Ende, Arie; Pfister, Hans-Walter; Giese, Armin; Beek, Diederik; Koedel, Uwe // Acta Neuropathologica;Apr2014, Vol. 127 Issue 4, p553 

    Cerebrovascular complications are common in pneumococcal meningitis and are a main determinant of unfavourable outcome and death. We hypothesized that plasminogen activator inhibitor-1 (PAI-1) is a major contributor to cerebrovascular complications and death in pneumococcal meningitis. In a...

  • Telavancin: A novel lipoglycopeptide antimicrobial agent. Attwood, Ryan J.; LaPlante, Kerry L. // American Journal of Health-System Pharmacy;11/15/2007, Vol. 64 Issue 22, p2335 

    Purpose. The pharmacology, activity, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, dosage, and place in therapy of telavancin are reviewed. Summary. Telavancin is a lipoglycopeptide antimicrobial agent under development for use in the treatment of multidrug-resistant...

  • Effects of omentectomy on the peritoneal fibrinolytic system. Celal Cerci; Erol Eroglu; Recep Sutcu; Bilal Celikbas; Aynur Kilbas // Surgery Today;Aug2008, Vol. 38 Issue 8, p711 

    Abstract Purpose  Decreased fibrinolytic activity in the serosal surfaces of peritoneal tissue appears to be a major factor in the development of peritoneal fibrous adhesions. The omentum reduces peritoneal adhesion by creating a mechanical barrier and producing fibrinolytic factors. This...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics